These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33243194)

  • 1. First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report.
    Weisschuh N; Mazzola P; Heinrich T; Haack T; Wissinger B; Tonagel F; Kelbsch C
    BMC Med Genet; 2020 Nov; 21(1):236. PubMed ID: 33243194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.
    Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF
    Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.
    Yu-Wai-Man P; Shankar SP; Biousse V; Miller NR; Bean LJ; Coffee B; Hegde M; Newman NJ
    Ophthalmology; 2011 Mar; 118(3):558-63. PubMed ID: 21036400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant optic atrophy caused by a novel OPA1 splice site mutation (IVS20+1G-->A) associated with intron retention.
    Hayashi T; Gekka T; Omoto S; Takeuchi T; Kitahara K
    Ophthalmic Res; 2005; 37(4):214-24. PubMed ID: 16006781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations.
    Yu-Wai-Man P; Bailie M; Atawan A; Chinnery PF; Griffiths PG
    Eye (Lond); 2011 May; 25(5):596-602. PubMed ID: 21378995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.
    Chen Y; Jia X; Wang P; Xiao X; Li S; Guo X; Zhang Q
    Mol Vis; 2013; 19():292-302. PubMed ID: 23401657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic Optic Atrophy 1 (
    Othman BA; Ong JE; Dumitrescu AV
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.
    Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V
    Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect.
    Thiselton DL; Alexander C; Morris A; Brooks S; Rosenberg T; Eiberg H; Kjer B; Kjer P; Bhattacharya SS; Votruba M
    Hum Genet; 2001 Nov; 109(5):498-502. PubMed ID: 11735024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier.
    Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M
    Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.
    Hayashi T; Sasano H; Katagiri S; Tsunoda K; Kameya S; Nakazawa M; Iwata T; Tsuneoka H
    Jpn J Ophthalmol; 2017 Sep; 61(5):395-401. PubMed ID: 28668999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
    Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
    Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
    Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
    Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AFG3L2 and ACO2-Linked Dominant Optic Atrophy: Genotype-Phenotype Characterization Compared to OPA1 Patients.
    Amore G; Romagnoli M; Carbonelli M; Cascavilla ML; De Negri AM; Carta A; Parisi V; Di Renzo A; Schiavi C; Lenzetti C; Zenesini C; Ormanbekova D; Palombo F; Fiorini C; Caporali L; Carelli V; Barboni P; La Morgia C
    Am J Ophthalmol; 2024 Jun; 262():114-124. PubMed ID: 38278202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells.
    Sladen PE; Jovanovic K; Guarascio R; Ottaviani D; Salsbury G; Novoselova T; Chapple JP; Yu-Wai-Man P; Cheetham ME
    Hum Mol Genet; 2022 Oct; 31(20):3478-3493. PubMed ID: 35652445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
    Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation spectrum of the OPA1 gene in a large cohort of patients with suspected dominant optic atrophy: Identification and classification of 48 novel variants.
    Weisschuh N; Schimpf-Linzenbold S; Mazzola P; Kieninger S; Xiao T; Kellner U; Neuhann T; Kelbsch C; Tonagel F; Wilhelm H; Kohl S; Wissinger B
    PLoS One; 2021; 16(7):e0253987. PubMed ID: 34242285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy.
    Ahuja AS; Selvam P; Vadlamudi C; Chopra H; Richter JE; Macklin SK; Samreen A; Helmi H; Mohammaad AN; Hines S; Davila MC; Atwal PS; Caulfield TR
    Ophthalmic Genet; 2020 Dec; 41(6):563-569. PubMed ID: 32940104
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Nitta Y; Osaka J; Maki R; Hakeda-Suzuki S; Suzuki E; Ueki S; Suzuki T; Sugie A
    Elife; 2024 Aug; 12():. PubMed ID: 39177028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy.
    Fuhrmann N; Alavi MV; Bitoun P; Woernle S; Auburger G; Leo-Kottler B; Yu-Wai-Man P; Chinnery P; Wissinger B
    J Med Genet; 2009 Feb; 46(2):136-44. PubMed ID: 19181907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.